Peggy Dennis
@peggyddennisWife, mother, new grandmother, surviving lung cancer. Patient Community Council @FoundationATCG. Co-chair- Survivor Advisory Council @teamsurviveit.
Similar User
@RhondaMeckstro1
@mrgieske
@CQiongWu
@LiveLung1
@KimballKristen
@heidi_onda
@LungCancerDude
@paulalv
@nitasfab5
@kasedill
@SLPChitChat
@UnmaskingC
@LauraJBook
@ALKPositiveinc
@KRASKickers
Sharing our stories. Thank you Health Monitor Network for sharing mine. theinsightfulbreath.com/2019/01/25/tel… @HealthMonitor @chrisdraft @lcsmchat #LCSM #lungcancer
Every year since 2018 we have gathered 5 or more year survivors of lung cancer together at CU to show others that hope has a face. This is the May 11th 2024 gathering. Rock on!
One step closer in expanding access for Biomarker testing in Colorado! SB 24-124 passed 8 - 1 in the Senate Committee for HHS & referred to Appropriations. An honor to add my testimony to help ensure ALL patients have access to testing➡️best possible treatments options #LCSM #ACS
Important open-access article for patients with actionable mutations/fusions #NSCLC--Bravo to @CUAnschutz @DRCamidge @TejasPatilMD and #radonc colleagues at #UCDenver advancesradonc.org/article/S2452-…
I'm thrilled to share our article "The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC" - now in @JTOonline! ➡️jtocrr.org/article/S2666-… 👇🏾DETAILS BELOW!
November is Lung Cancer Awareness Month. We honor all of those within and beyond our community who have had and are living with lung cancer. #LungCancerAwarenessMonth
Both our tissue- & blood-based #genomic #profiling #tests are now FDA-approved to identify patients w/ metastatic #NSCLC harboring a BRAF V600E mutation who may benefit from treatment w/ a targeted combination therapy. Click here to learn more: bit.ly/3rHcmEi
#Announcement 📣: Our tissue-informed circulating tumor DNA monitoring test is now available to all physicians in the US seeking personalized monitoring of their patients' response to treatment. More on this #Launch news: bit.ly/3rQcy3R
New FDA Approval – today we announced that our tissue-based genomic profiling test is now FDA approved to identify patients with solid tumors with RET gene fusions who may benefit from a #TargetedTherapy. Learn more about the announcement here: ow.ly/uNpq50PUxQ7
Dark day for #EGFR #exon20 pts when discussions betw. @FDAOncology & @TakedaOncology led to a decision re #mobocertinib's withdrawal (timing unclear). No words! We've worked w/mobo since early 2017 & need it to be available as one of our 2 anchor drugs. 844-662-8532 (Takeda info)
This is a huge blow for UK-based #Exon20 patients like me. Particularly as Mobo was found to be as effective as chemo in EXCLAIM-2... it just failed to show superiority over it. EXCLAIM-1 already demonstrated efficacy beyond 1st line. So its withdrawal is devastating!
Very informative NCI Cancer Diagnosis Program Workshop! Thank you, Dr. Mansfield for sharing your unique perspective presentation on “Regulatory consideration for ctDNA assays.” @LCSM @Exon20IRC #ctDNA #clinicaltrials @NIH #nationalcancerinstitute @blood_pac
This week - Elizabeth Mansfield, PhD, VP, Regulatory Policy will be speaking at the NCI Cancer Diagnosis Program Workshop: ctDNA in Cancer Treatment and Clinical Care presenting on "Regulatory consideration for ctDNA assays." Learn more at the link here: bit.ly/3PwwBgW
My friend Lisa lived large. Her story lives on. #lcsm
This week - Elizabeth Mansfield, PhD, VP, Regulatory Policy will be speaking at the NCI Cancer Diagnosis Program Workshop: ctDNA in Cancer Treatment and Clinical Care presenting on "Regulatory consideration for ctDNA assays." Learn more at the link here: bit.ly/3PwwBgW
Now FDA approved - FoundationOne®CDx* to identify adult patients w/ mCRPC harboring BRCA1- or BRCA2-positive mutations who may benefit from a new targeted treatment: bit.ly/3YAWaQE *Rx only; advanced cancer; doesn't guarantee treatment match F1CDxLabel.com
#Mobocertinib is my 7th line treatment since stg 4 Dx 7 yrs ago. With every treatment, managing toxicities was/is key. 14 mo & counting on Mobo w/ profound response. Many LC patients are benefiting. PLS do not withdraw! @JackWestMD @BiljoyTelivala @FDAOncology #LCSM @Exon20Group
@Exon20Group disagrees.#Mobocertinib can restore breathing in days, pts get more time & can do well. We've seen pts w/2+ yr PFS (2017-now) + manageable tox.We need #mobo pre/post screen fails & sunvo needs to accept pretreated mobo! @JackWestMD @BijoyTelivala @FDAOncology
I really like this retrospective study in @JTOonline on #EGFR Exon 20 #lungcancer. PCR tests misses MANY EGFR variants; highlights importance of comprehensive (not piecemeal) #NGS testing. @lcsmchat @EGFRResisters 👉🏾jto.org/article/S1556-…
The level of circulating tumor DNA (ctDNA) shed by a patient’s specific tumor informs the accuracy of blood-based CGP test results. Through a tumor fraction algorithm, our scientists developed a method for quantifying ctDNA in each blood sample: bit.ly/42nOIsy #ASCO23
Another great list of #lungcancer sessions at #ASCO23! #LCSM
Foundation Medicine at #ASCO23 - 21 new pieces of research demonstrating advancements in #cancer monitoring, expanded #liquidbiopsy capabilities and the validity and utility of complex #biomarker detection. Learn more: bit.ly/43b9ahy
ctDNA testing has potential to transform care w/ real-time assessments of prognosis & treatment response using a simple blood draw. Our research in @NatureMedicine used machine learning to model ctDNA metrics in NSCLC patients to predict overall survival: bit.ly/3WtJPwC
United States Trends
- 1. SEVENTEEN 1,05 Mn posts
- 2. #UFCMacau 8.700 posts
- 3. #ArcaneSeason2 46,7 B posts
- 4. woozi 285 B posts
- 5. Ekko 26,4 B posts
- 6. BIGBANG 288 B posts
- 7. Kavanagh N/A
- 8. JUNGKOOK 513 B posts
- 9. #arcane2spoilers 1.540 posts
- 10. Ochoa 6.599 posts
- 11. jikook 10,8 B posts
- 12. scoups 40,4 B posts
- 13. Motta 4.327 posts
- 14. #GDRAGONxMAMA2024 118 B posts
- 15. cheol 13,7 B posts
- 16. #Caitvi 42,6 B posts
- 17. soyeon N/A
- 18. jeonghan 73,7 B posts
- 19. Kyrie 9.768 posts
- 20. Caleb Love 1.825 posts
Who to follow
-
Rhonda Meckstroth
@RhondaMeckstro1 -
Michael Gieske, M.D.
@mrgieske -
Christine Qiong Wu
@CQiongWu -
LiveLung
@LiveLung1 -
kristen kimball
@KimballKristen -
Heidi Nafman-Onda
@heidi_onda -
Stephen Huff
@LungCancerDude -
Paula
@paulalv -
Juanita Segura
@nitasfab5 -
KC Dill
@kasedill -
Rosemary Conway
@SLPChitChat -
Unmasking the Reality of Lung Cancer
@UnmaskingC -
Laura Book
@LauraJBook -
ALK Positive
@ALKPositiveinc -
KRASKickers
@KRASKickers
Something went wrong.
Something went wrong.